We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
(+5.5%)
Cap. Flow
+$20.5M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$47.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$38.9M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$24.1M |
| 4 |
Netflix
NFLX
|
+$21.5M |
| 5 |
Waste Management
WM
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$45.3M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$33.2M |
| 3 |
Danaher
DHR
|
+$28.3M |
| 4 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$25.2M |
| 5 |
Healthcare Services Group
HCSG
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Technology | 15.43% |
| 3 | Financials | 11.87% |
| 4 | Industrials | 11.27% |
| 5 | Consumer Discretionary | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EEQ
1101
DELISTED
Enbridge Energy Management Llc
EEQ
| $219K | ﹤0.01% |
+10,599
| New | +$202K |
|
1102
Western Midstream Partners
WES
$19.3B
| $218K | ﹤0.01% |
+5,140
| New | +$194K |
|
|
HDS
1103
DELISTED
HD Supply Holdings, Inc.
HDS
| $218K | ﹤0.01% |
6,805
-27,850
| -80% | -$964K |
|
|
WWAV
1104
DELISTED
The WhiteWave Foods Company
WWAV
| $218K | ﹤0.01% |
4,006
-18,705
| -82% | -$1.03M |
|
1105
CNA Financial
CNA
$14.3B
| $217K | ﹤0.01% |
+6,306
| New | +$205K |
|
1106
Prologis
PLD
$130B
| $216K | ﹤0.01% |
+4,028
| New | +$213K |
|
1107
Boston Beer
SAM
$1.92B
| $216K | ﹤0.01% |
+1,388
| New | +$242K |
|
|
WR
1108
DELISTED
Westar Energy Inc
WR
| $216K | ﹤0.01% |
3,800
-300
| -7% | -$16.6K |
|
1109
iShares US Financials ETF
IYF
$4.62B
| $215K | ﹤0.01% |
+4,770
| New | +$214K |
|
|
CARB
1110
DELISTED
Carbonite Inc
CARB
| $215K | ﹤0.01% |
14,000
+3,500
| +33% | +$44.4K |
|
|
GPX
1111
DELISTED
GP Strategies Corp.
GPX
| $214K | ﹤0.01% |
8,705
-4,138
| -32% | -$96.1K |
|
1112
Arista Networks
ANET
$240B
| $213K | ﹤0.01% |
+40,000
| New | +$191K |
|
1113
Huntington Ingalls Industries
HII
$12.7B
| $213K | ﹤0.01% |
1,391
| – | – |
|
1114
Raymond James Financial
RJF
$34.3B
| $213K | ﹤0.01% |
+5,481
| New | +$202K |
|
1115
Ribbon Communications
RBBN
$388M
| $212K | ﹤0.01% |
27,229
+8,000
| +42% | +$69.9K |
|
1116
American Water Works
AWK
$26.6B
| $211K | ﹤0.01% |
+2,815
| New | +$220K |
|
|
AVNS
1117
DELISTED
Avanos Medical
AVNS
| $210K | ﹤0.01% |
6,046
-1,011
| -14% | -$35.4K |
|
1118
Interparfums
IPAR
$4.12B
| $209K | ﹤0.01% |
+6,485
| New | +$207K |
|
1119
Trinity Industries
TRN
$2.55B
| $209K | ﹤0.01% |
+12,029
| New | +$198K |
|
|
INFN
1120
DELISTED
Infinera Corporation Common Stock
INFN
| $209K | ﹤0.01% |
23,090
+9,640
| +72% | +$93.2K |
|
1121
Helios Technologies
HLIO
$2.69B
| $208K | ﹤0.01% |
+6,459
| New | +$195K |
|
1122
Sony
SONY
$131B
| $208K | ﹤0.01% |
31,335
-9,115
| -23% | -$58.4K |
|
1123
Aptiv
APTV
$10.1B
| $207K | ﹤0.01% |
+2,907
| New | +$196K |
|
|
IFN
1124
Aberdeen India Fund
IFN
$506M
| $207K | ﹤0.01% |
8,308
| – | – |
|
1125
Teradyne
TER
$63.1B
| $207K | ﹤0.01% |
+9,572
| New | +$198K |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2016 Portfolio in Review
As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
- William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
- William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
- William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
- William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
- William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
- William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.
Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.